Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-04-03-Speech-2-294"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-04-03"^^xsd:date2
dcterms:Is Part Of	lp_eu:Public health action programme (2001-2006)2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20010403.12.2-294"2
lpv:hasSubsequent	lp_eu:2001-04-03-Speech-2-2952
lpv:speaker	lp:Karin Jöns2
lpv:spokenAs	substitute; BUDG (1999-07-22--2002-01-14)3,3 member; Members from the European Parliament to the Joint Parliamentary Assembly of the Agreement between the African, Caribbean and Pacific States and the European Union (ACP-EU) (1999-09-14--2002-01-14)3,3 member; EMPL (1999-07-21--2002-01-14)3,3 member; PES (1999-07-20--2004-07-19)3,3 unknown; Sozialdemokratische Partei Deutschlands (1999-07-20--2004-07-19)3,3 substitute; Committee on Women's Rights and Equal Opportunities (1999-07-22--2002-01-14)3,3
lpv:translated text	"Mr President, ladies and gentlemen, first of all, I should like to thank Mr Trakatellis very warmly for his excellent report. But thanks are also due to the committee responsible, which accepted all 16 amendments proposed by the Committee on Women's Rights. This shows that once again, this House is much further ahead than some Member States with their national health policies. Although we women constitute the majority of the population, and although the double and triple burden of work, family and caring for relatives are shown to take a greater toll on our health, women-specific aspects do not always receive the attention they deserve in health policy. Our health systems are usually gender-blind. National reports rarely include a breakdown by gender. Yet it is telling that in Europe and beyond, the majority of people who are dependent on medication are women. In Germany, the figure is 70%. So we urgently need more solid data, and above all, a holistic approach to health throughout Europe. Gender policies must also be granted a central role in health policy in future: in research, prevention and treatment. The new Public Health Action Programme can pave the way in this regard. Every 20 minutes, a woman dies of breast cancer in Europe. It affects one woman in nine. The probability of contracting this disease increases from year to year. Yet if it is detected in time and properly treated, breast cancer is curable. So here too, best practice is imperative. We must ensure that it is not only in early detection that breakthroughs are widely promoted throughout the EU. After the adoption of the European Guidelines for Quality Assurance in Mammography Screening, the task now is to research and promote best practice for treatment as well."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph